Alpenglow Biosciences launches LUMI, a new user interface designed to simplify light-sheet microscopy and 3D imaging workflows, debuting at ABRF 2025.

Alpenglow Biosciences and Incyte Corporation will present groundbreaking 3D imaging research at SID 2025, showcasing how 3D imaging reveals neuroimmune dynamics in atopic dermatitis treated with ruxolitinib cream. Using Alpenglow’s Aurora 3Di light-sheet microscopy, the study provides unprecedented insights into nerve volume, immune cell distribution, and epidermal remodeling.

Alpenglow unveils a $50,000 research grant program for novel applications of its brand new 3D I/O Pro assay. Unlock insights into the tumor microenvironment with whole tissue 3D imaging and analysis.

We have developed the 3D Derm Score Assay to reveal the complexities of the skin microenvironment and determine the relationship between critical structures in the epidermis and dermis.

Alpenglow Biosciences sponsors dinner lecture titles “Decoding Immune Exclusion and Tumor Evasion in the TME” during the 2023 annual SITC meeting

Alpenglow Biosciences presents the 3D Spatial Summit, an inaugural event for the field of 3D Spatial Biology to take place on September 21, 2023 in Cambridge, Massachusetts

Alpenglow Biosciences awarded $1.6M grant to develop AI-enabled smart microscopy and 3D database of cancer biopsies